U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 225

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:37059022
GRCh38:
Chr3:37017531
MLH1R240fs, R32fs, R175fs, R273fsHereditary cancer-predisposing syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Pathogenic/Likely pathogenic
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr2:48010683-48030509
MSH6Turcot syndromeLikely pathogenic
(Sep 3, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr2:48033378-48033379
GRCh38:
Chr2:47806239-47806240
MSH6N1099fs, N1229fs, N927fsTurcot syndromeLikely pathogenic
(Oct 21, 2020)
criteria provided, single submitter
4.
GRCh37:
Chr3:37089052
GRCh38:
Chr3:37047561
MLH1S234G, S251G, S351G, S494G, S559G, S592GHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasmsUncertain significance
(Dec 14, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr3:37053318
GRCh38:
Chr3:37011827
MLH1V152I, V185I, V87IHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Conflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr3:37038178
GRCh38:
Chr3:36996687
MLH1Q62RHereditary nonpolyposis colorectal neoplasms, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome,
Muir-Torré syndrome
Uncertain significance
(Apr 9, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr2:48026559-48026560
GRCh38:
Chr2:47799420-47799421
MSH6V178fs, V350fs, V480fsTurcot syndromePathogenic
(Jun 5, 2020)
criteria provided, single submitter
8.
PMS2Turcot syndromePathogenic
(May 6, 2020)
no assertion criteria provided
9.
GRCh37:
Chr7:6045664
GRCh38:
Chr7:6006033
PMS2Turcot syndromePathogenic
(May 2, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr3:37053501
GRCh38:
Chr3:37012010
MLH1Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome
Pathogenic/Likely pathogenic
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr7:6017213
GRCh38:
Chr7:5977582
PMS2Hereditary nonpolyposis colorectal neoplasms, Turcot syndrome, not provided
Uncertain significance
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr7:6043693
GRCh38:
Chr7:6004062
PMS2Hereditary nonpolyposis colorectal neoplasms, Turcot syndromeConflicting interpretations of pathogenicity
(Apr 17, 2019)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr7:6031628
GRCh38:
Chr7:5991997
PMS2V11F, V131F, V187F, V322F, V216F, V219FHereditary nonpolyposis colorectal neoplasms, Turcot syndromeUncertain significance
(Aug 28, 2021)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr3:37092127
GRCh38:
Chr3:37050636
MLH1V411L, V654L, V752L, V683L, V721L, V394L, V511L, V697L, V719LTurcot syndrome, Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Uncertain significance
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr7:6027264-6027282
GRCh38:
Chr7:5987633-5987651
PMS2Turcot syndromeUncertain significance
(Aug 25, 2019)
no assertion criteria provided
16.
GRCh37:
Chr3:37090475
GRCh38:
Chr3:37048984
MLH1Y332*, Y449*, Y592*, Y657*, Y635*, Y659*, Y690*, Y349*Hereditary nonpolyposis colorectal neoplasms, not provided, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr3:37042467
GRCh38:
Chr3:37000976
MLH1C77GHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary cancer-predisposing syndrome
Uncertain significance
(Nov 18, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr3:37059048
GRCh38:
Chr3:37017557
MLH1A248G, A40G, A183G, A281GHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr3:37055971
GRCh38:
Chr3:37014480
MLH1M242I, M1I, M144I, M209IHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided,
Turcot syndrome, Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Uncertain significance
(Sep 3, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr3:37061800
GRCh38:
Chr3:37020309
MLH1Hereditary cancer-predisposing syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Pathogenic/Likely pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr2:47639559-47639560
GRCh38:
Chr2:47412420-47412421
MSH2R153fs, R219fsHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasmsPathogenic
(Apr 25, 2023)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr2:48033959
GRCh38:
Chr2:47806820
MSH6E1348A, E1218A, E1046Anot provided, Turcot syndrome, Endometrial carcinoma,
Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Uncertain significance
(Aug 12, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr3:37067140
GRCh38:
Chr3:37025649
MLH1G351R, G10R, G253R, G110R, G318RHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr3:37053562
GRCh38:
Chr3:37012071
MLH1R217S, R119S, R184SHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr7:6037045
GRCh38:
Chr7:5997414
PMS2L239F, L133F, L48F, L104F, L136FHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Lynch syndrome 4
Uncertain significance
(Oct 2, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr7:6043433
GRCh38:
Chr7:6003802
PMS2Hereditary nonpolyposis colorectal neoplasms, not providedUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr7:6045611
GRCh38:
Chr7:6005980
PMS2Q25HHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Turcot syndrome,
Lynch syndrome 4
Uncertain significance
(Jan 28, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr7:6038772
GRCh38:
Chr7:5999141
PMS2K224N, K89N, K121N, K118NTurcot syndrome, Lynch syndrome 4, Hereditary cancer-predisposing syndrome,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Feb 8, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr2:47637330
GRCh38:
Chr2:47410191
MSH2V155A, V89ATurcot syndrome, Lynch syndrome 1, Muir-Torré syndrome,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided
Conflicting interpretations of pathogenicity
(Sep 25, 2023)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr3:37089179
GRCh38:
Chr3:37047688
MLH1Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Colorectal cancer, hereditary nonpolyposis, type 2,
Turcot syndrome, Muir-Torré syndrome, not provided
Uncertain significance
(Jan 26, 2023)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr7:6027232
GRCh38:
Chr7:5987601
PMS2H201fs, H282fs, H285fs, H336fs, H388fs, H197fs, H77fs, H253fsTurcot syndrome, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Pathogenic
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr2:48027305
GRCh38:
Chr2:47800166
MSH6K728R, K598R, K426RHereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Lynch syndrome 5, Turcot syndrome, Endometrial carcinoma
Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr3:37035091
GRCh38:
Chr3:36993600
MLH1R18HHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Uncertain significance
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr3:37059050
GRCh38:
Chr3:37017559
MLH1A282T, A249T, A41T, A184THereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Uncertain significance
(Jun 30, 2023)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr2:48027637
GRCh38:
Chr2:47800498
MSH6D839H, D537H, D709HHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Endometrial carcinoma,
Lynch syndrome 5, Turcot syndrome
Uncertain significance
(Jun 19, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr2:48010556
GRCh38:
Chr2:47783417
MSH6R62CLynch syndrome 5, Turcot syndrome, Endometrial carcinoma,
Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
not specified
Uncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr3:37035028
GRCh38:
Chr3:36993537
MLH1Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer, hereditary nonpolyposis, type 2,
Turcot syndrome, Muir-Torré syndrome, not provided
Uncertain significance
(Aug 3, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr3:37035129
GRCh38:
Chr3:36993638
MLH1A31THereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome, Muir-Torré syndrome
Uncertain significance
(Sep 22, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr2:48027422
GRCh38:
Chr2:47800283
MSH6T767S, T465S, T637SHereditary nonpolyposis colorectal neoplasms, Endometrial carcinoma, Lynch syndrome 5,
Turcot syndrome, Hereditary cancer-predisposing syndrome, Lynch syndrome 5,
not provided
Conflicting interpretations of pathogenicity
(Mar 27, 2023)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr7:6031643
GRCh38:
Chr7:5992012
PMS2Q317K, Q182K, Q126K, Q214K, Q6K, Q211KHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Turcot syndrome, Lynch syndrome 4
Uncertain significance
(Jun 6, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr2:48026755
GRCh38:
Chr2:47799616
MSH6K545E, K415E, K243EHereditary cancer-predisposing syndrome, Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms,
not provided, Endometrial carcinoma, Turcot syndrome,
Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr3:37059027
GRCh38:
Chr3:37017536
MLH1K274R, K176R, K33R, K241Rnot provided, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome, Muir-Torré syndrome
Uncertain significance
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr7:6026468
GRCh38:
Chr7:5986837
PMS2Q643R, Q456R, Q508R, Q540R, Q452R, Q332R, Q537R, Q591RHereditary cancer-predisposing syndrome, not specified, Turcot syndrome,
Lynch syndrome 4, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr2:48026392
GRCh38:
Chr2:47799253
MSH6V424I, V122I, V294IHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Lynch syndrome 5,
Endometrial carcinoma, Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:48010476
GRCh38:
Chr2:47783337
MSH6A35VHereditary cancer-predisposing syndrome, Turcot syndrome, Endometrial carcinoma,
Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms, not specified,
not provided
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr3:37067239
GRCh38:
Chr3:37025748
MLH1V384I, V143I, V26I, V286I, V351I, V43IHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Turcot syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2
Uncertain significance
(Dec 14, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr7:6027020
GRCh38:
Chr7:5987389
PMS2S459*, S148*, S272*, S356*, S268*, S353*, S407*, S324*not provided, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr3:37090378
GRCh38:
Chr3:37048887
MLH1not specified, Hereditary nonpolyposis colorectal neoplasms, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Likely benign
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr2:47641560
GRCh38:
Chr2:47414421
MSH2Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome,
Breast and/or ovarian cancer, not specified, Turcot syndrome,
Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Aug 22, 2023)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr7:6013098
GRCh38:
Chr7:5973467
PMS2W530fs, W706fs, W717fs, W735fs, W738fs, W852fs, W650fs, W789fs, W841fs, W654fsHereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Turcot syndrome
Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr7:6038782
GRCh38:
Chr7:5999151
PMS2P221L, P118L, P115L, P86LHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 24, 2021)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr7:6043315
GRCh38:
Chr7:6003684
PMS2Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome,
not specified, not provided, Lynch syndrome 4
Conflicting interpretations of pathogenicity
(Sep 5, 2023)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr3:37042464
GRCh38:
Chr3:37000973
MLH1V76IHereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome,
not specified, not provided, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr7:6043346
GRCh38:
Chr7:6003715
PMS2A110Snot provided, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
Lynch syndrome 4, Turcot syndrome
Uncertain significance
(Jun 16, 2023)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr7:6038769
GRCh38:
Chr7:5999138
PMS2E225D, E90D, E119D, E122DHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
not specified, Lynch syndrome 4, Turcot syndrome
Uncertain significance
(Sep 7, 2023)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr2:48032060
GRCh38:
Chr2:47804921
MSH6L1150F, L848F, L1020Fnot provided, Lynch syndrome 5, Hereditary cancer-predisposing syndrome,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr2:48033498
GRCh38:
Chr2:47806359
MSH6Hereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Lynch syndrome 5, Endometrial carcinoma, Turcot syndrome
Likely pathogenic
(Jan 30, 2023)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr7:6029563
GRCh38:
Chr7:5989932
PMS2P338A, P232A, P147A, P27A, P203A, P235ABreast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms,
not provided
Uncertain significance
(Nov 14, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr3:37042480
GRCh38:
Chr3:37000989
MLH1T81SHereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not specified,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr7:6026820
GRCh38:
Chr7:5987189
PMS2D526N, D215N, D423N, D335N, D391N, D339N, D420N, D474Nnot provided, Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4,
Turcot syndrome, Hereditary cancer-predisposing syndrome, not specified
Conflicting interpretations of pathogenicity
(Jul 31, 2023)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr7:6035243
GRCh38:
Chr7:5995612
PMS2Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Lynch syndrome 4, Turcot syndrome, Lynch syndrome 4
Pathogenic/Likely pathogenic
(Dec 9, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr7:6013059
GRCh38:
Chr7:5973428
PMS2A854T, A543T, A719T, A865T, A663T, A667T, A730T, A802T, A748T, A751THereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4, Turcot syndrome,
not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 7, 2023)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr3:37059014
GRCh38:
Chr3:37017523
MLH1T270A, T237A, T29A, T172AHereditary nonpolyposis colorectal neoplasms, not specified, not provided,
Hereditary cancer-predisposing syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Conflicting interpretations of pathogenicity
(Mar 20, 2023)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr2:47702229
GRCh38:
Chr2:47475090
MSH2A609S, A543SHereditary cancer-predisposing syndrome, MSH2-related condition, not provided,
Lynch syndrome 1, Muir-Torré syndrome, Turcot syndrome,
Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Nov 16, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr2:48030698
GRCh38:
Chr2:47803559
MSH6F1104L, F974L, F802LHereditary cancer-predisposing syndrome, not specified, Turcot syndrome,
Lynch syndrome 5, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms,
not provided
Conflicting interpretations of pathogenicity
(Feb 6, 2023)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr2:48010559
GRCh38:
Chr2:47783420
MSH6S63PHereditary cancer-predisposing syndrome, not provided, Lynch syndrome 5,
Endometrial carcinoma, Turcot syndrome, Lynch syndrome 5,
MSH6-related condition, Hereditary nonpolyposis colorectal neoplasms, not specified
Conflicting interpretations of pathogenicity
(Mar 27, 2023)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr7:6017284
GRCh38:
Chr7:5977653
PMS2P794S, P483S, P691S, P688S, P603S, P607S, P670S, P742S, P805S, P659Snot provided, Turcot syndrome, Lynch syndrome 4,
Lynch syndrome 4, Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer,
Hereditary cancer-predisposing syndrome, not specified
Uncertain significance
(Jul 25, 2023)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr3:37053563
GRCh38:
Chr3:37012072
MLH1R217H, R184H, R119HHereditary nonpolyposis colorectal neoplasms, not provided, Turcot syndrome,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Oct 8, 2023)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr3:37048539
GRCh38:
Chr3:37007048
MLH1Lynch syndromeLikely benign
(Oct 18, 2018)
reviewed by expert panel
70.
GRCh37:
Chr3:37089053
GRCh38:
Chr3:37047562
MLH1S592N, S351N, S234N, S494N, S559N, S251NHereditary cancer-predisposing syndrome, not provided, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome, not specified,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Oct 16, 2023)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr3:37067207
GRCh38:
Chr3:37025716
MLH1G373E, G132E, G32E, G15E, G275E, G340EHereditary nonpolyposis colorectal neoplasms, Turcot syndrome, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr7:6026844
GRCh38:
Chr7:5987213
PMS2E518K, E207K, E415K, E331K, E383K, E412K, E327K, E466Knot provided, Lynch syndrome 4, Turcot syndrome,
Hereditary cancer-predisposing syndrome, Lynch syndrome 4, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Sep 14, 2023)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr2:47702206
GRCh38:
Chr2:47475067
MSH2Q601R, Q535Rnot specified, Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1,
Turcot syndrome, Muir-Torré syndrome, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Nov 25, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:48010508
GRCh38:
Chr2:47783369
MSH6G46RHereditary cancer-predisposing syndrome, Lynch syndrome 5, Endometrial carcinoma,
Turcot syndrome, Lynch syndrome 5, not provided,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Sep 6, 2023)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr2:47705579
GRCh38:
Chr2:47478440
MSH2Q793H, Q727HHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Turcot syndrome
Conflicting interpretations of pathogenicity
(Jul 20, 2023)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr2:47657058
GRCh38:
Chr2:47429919
MSH2I418M, I352MHereditary nonpolyposis colorectal neoplasms, not specified, MSH2-related condition,
Hereditary cancer-predisposing syndrome, not provided, Turcot syndrome,
Muir-Torré syndrome, Lynch syndrome 1, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Jun 28, 2023)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr2:48026027
GRCh38:
Chr2:47798888
MSH6R302K, R172K, R127K, R203K, R246K, R276K, R304K, R334KHereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr2:48010508
GRCh38:
Chr2:47783369
MSH6G46RLynch syndrome 5, Endometrial carcinoma, Turcot syndrome,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(May 26, 2023)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr3:37081690
GRCh38:
Chr3:37040199
MLH1M524I, M166I, M283I, M426I, M491I, M183IHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2
Conflicting interpretations of pathogenicity
(Jul 13, 2023)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr2:47637269
GRCh38:
Chr2:47410130
MSH2L135V, L69Vnot specified, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms,
not provided, Muir-Torré syndrome, Turcot syndrome,
Lynch syndrome 1, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr2:48028081
GRCh38:
Chr2:47800942
MSH6T987A, T685A, T857AHereditary cancer-predisposing syndrome, not specified, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, not provided, Turcot syndrome,
Endometrial carcinoma, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Mar 28, 2023)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr2:47637242
GRCh38:
Chr2:47410103
MSH2G126S, G60SHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Muir-Torré syndrome,
Turcot syndrome, Lynch syndrome 1
Uncertain significance
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr3:37067206
GRCh38:
Chr3:37025715
MLH1G373R, G132R, G32R, G340R, G15R, G275RHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
not specified, Muir-Torré syndrome, Colorectal cancer, hereditary nonpolyposis, type 2,
Turcot syndrome, Lynch syndrome, Colorectal cancer, hereditary nonpolyposis, type 2
Conflicting interpretations of pathogenicity
(May 5, 2023)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr7:6026837
GRCh38:
Chr7:5987206
PMS2A520V, A414V, A209V, A329V, A333V, A385V, A417V, A468VHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Breast and/or ovarian cancer,
not specified, not provided, Lynch syndrome 4,
Turcot syndrome, Lynch syndrome 4, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr3:37042528
GRCh38:
Chr3:37001037
MLH1Y97C, M1Vnot specified, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms,
not provided, Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome
Conflicting interpretations of pathogenicity
(May 12, 2023)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr7:6043425
GRCh38:
Chr7:6003794
PMS2not provided, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colon cancer,
Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, Turcot syndrome,
Lynch syndrome 4, Lynch syndrome, Lynch syndrome 4
Pathogenic/Likely pathogenic
(Apr 4, 2023)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr2:48027350-48027351
GRCh38:
Chr2:47800211-47800212
MSH6E442fs, E614fs, E744fsHereditary nonpolyposis colon cancer, MSH6-related condition, Hereditary nonpolyposis colorectal neoplasms,
Hereditary cancer-predisposing syndrome, not provided, Lynch syndrome 5
Pathogenic/Likely pathogenic
(Jul 10, 2023)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr2:48010382
GRCh38:
Chr2:47783243
MSH6Q4*Hereditary nonpolyposis colorectal neoplasms, MSH6-related condition, Lynch syndrome 5,
Endometrial carcinoma, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome,
Breast and/or ovarian cancer, not provided, Lynch syndrome,
Lynch syndrome 5
Pathogenic/Likely pathogenic
(Mar 28, 2023)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr2:47703502
GRCh38:
Chr2:47476363
MSH2Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified,
not provided, Turcot syndrome, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr7:6042115
GRCh38:
Chr7:6002484
PMS2R169H, R34H, R63H, R66HHereditary nonpolyposis colorectal neoplasms, PMS2-related condition, Hereditary cancer-predisposing syndrome,
Turcot syndrome, Lynch syndrome 4, not provided,
Lynch syndrome
Uncertain significance
(Jun 22, 2023)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr7:6048649
GRCh38:
Chr7:6009018
PMS2M1KPMS2-related condition, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome,
not provided, Lynch syndrome 4, Turcot syndrome,
Lynch syndrome 4
Conflicting interpretations of pathogenicity
(Apr 4, 2023)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr2:48033708
GRCh38:
Chr2:47806569
MSH6N1307H, N1177H, N1005HHereditary cancer-predisposing syndrome, not provided, Turcot syndrome,
Lynch syndrome 5, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Jun 13, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr2:47637249
GRCh38:
Chr2:47410110
MSH2L128R, L62Rnot provided, Hereditary nonpolyposis colorectal neoplasms, not specified,
Hereditary cancer-predisposing syndrome, Lynch syndrome 1, Turcot syndrome,
Muir-Torré syndrome, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Aug 4, 2023)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr3:37067332
GRCh38:
Chr3:37025841
MLH1D415N, D57N, D74N, D174N, D317N, D382Nnot provided, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Turcot syndrome, Muir-Torré syndrome,
Breast and/or ovarian cancer
Uncertain significance
(Apr 19, 2023)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr3:37067125
GRCh38:
Chr3:37025634
MLH1Hereditary cancer-predisposing syndrome, Turcot syndrome, Muir-Torré syndrome,
Colorectal cancer, hereditary nonpolyposis, type 2, Hereditary nonpolyposis colorectal neoplasms, not provided
Conflicting interpretations of pathogenicity
(Jun 29, 2022)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr2:47702331
GRCh38:
Chr2:47475192
MSH2E643K, E577KHereditary nonpolyposis colorectal neoplasms, MSH2-related condition, Hereditary cancer-predisposing syndrome,
not specified, not provided, Lynch syndrome 1,
Turcot syndrome, Muir-Torré syndrome
Conflicting interpretations of pathogenicity
(Apr 3, 2023)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr3:37070354
GRCh38:
Chr3:37028863
MLH1R497W, R139W, R156W, R256W, R399W, R464WHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Apr 14, 2023)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr7:6036994
GRCh38:
Chr7:5997363
PMS2G256S, G121S, G150S, G153S, G65SHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Turcot syndrome, Lynch syndrome 4, Lynch syndrome 4
Uncertain significance
(Sep 5, 2023)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr7:6045598
GRCh38:
Chr7:6005967
PMS2Q30*Hereditary nonpolyposis colon cancer, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
Lynch syndrome, not provided, Turcot syndrome,
Lynch syndrome 1, Lynch syndrome 4
Pathogenic
(Mar 24, 2023)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr7:6035191
GRCh38:
Chr7:5995560
PMS2N293D, N102D, N158D, N187D, N190DPMS2-related condition, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
not specified, not provided, Lynch syndrome 4,
Turcot syndrome, Lynch syndrome, Lynch syndrome 4
Uncertain significance
(Oct 13, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination